Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Boehm A, Walcherberger B, Sperr WR, Wöhrer S, Dieckmann K, Rosenmayr A, Pernicka E, Fischer G, Worel N, Mitterbauer G, Schwarzinger I, Mitterbauer M, Haas OA, Lechner K, Hinterberger W, Valent P, Greinix HT, Rabitsch W, Kalhs P. Boehm A, et al. Among authors: fischer g. Biol Blood Marrow Transplant. 2011 Jan;17(1):133-40. doi: 10.1016/j.bbmt.2010.06.019. Epub 2010 Jul 1. Biol Blood Marrow Transplant. 2011. PMID: 20601032 Free article.
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Höcker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT. Worel N, et al. Among authors: fischer g. Bone Marrow Transplant. 2002 Nov;30(9):619-26. doi: 10.1038/sj.bmt.1703677. Bone Marrow Transplant. 2002. PMID: 12407437
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Greinix HT, Faé I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B, Kalhs P, Lechner K, Mayr WR, Fischer GF. Greinix HT, et al. Among authors: fischer gf. Bone Marrow Transplant. 2005 Jan;35(1):57-62. doi: 10.1038/sj.bmt.1704741. Bone Marrow Transplant. 2005. PMID: 15531903
Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.
Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Morishima Y, et al. Biol Blood Marrow Transplant. 2013 Aug;19(8):1197-203. doi: 10.1016/j.bbmt.2013.05.020. Epub 2013 Jun 6. Biol Blood Marrow Transplant. 2013. PMID: 23747601 Free PMC article.
In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.
Nachbaur D, Eibl B, Kropshofer G, Meister B, Mitterschiffthaler A, Schennach H, Fischer G, Kopp M, Gunsilius E, Gastl G. Nachbaur D, et al. Among authors: fischer g. J Hematother Stem Cell Res. 2002 Aug;11(4):731-7. doi: 10.1089/15258160260194884. J Hematother Stem Cell Res. 2002. PMID: 12201962
Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N, Greinix HT, Supper V, Leitner G, Mitterbauer M, Rabitsch W, Fischer G, Rosenmayr A, Höcker P, Kalhs P. Worel N, et al. Among authors: fischer g. Transfusion. 2007 Aug;47(8):1494-502. doi: 10.1111/j.1537-2995.2007.01289.x. Transfusion. 2007. PMID: 17655594
2,873 results